Medicine


Business Brief – August 16, 2018

U.S. Approves New Generic Competitor to EpiPen WASHINGTON (AP) — U.S. health officials have approved a new generic version of EpiPen, the emergency allergy medication. The Food and Drug Administration’s…

Read more »

NYU Offers Free Tuition for All Medical Students

New York University is offering free tuition for all its medical students. The Wall Street Journal reported Thursday that the move is a first among major U.S. medical schools. Rising…

Read more »

Trump Thanks Novartis, Pfizer for Not Raising Drug Prices

President Donald Trump thanked two major drug companies on Thursday for not raising their prices and said his administration was working toward substantially cutting prescription-drug prices. “Thank you to Novartis…

Read more »

FOCUS: New Weapons Against Antibiotic-Resistant Bacteria

It’s frustrating enough when progress in medicine plods along slowly, but downright alarming when it starts to backslide. Bacterial infections were considered essentially conquered in the 20th century, and now…

Read more »

‘Save a Child’s Heart’ Doctors Honored at U.N.

A group of Israeli doctors have bypassed the region’s politics to save thousands of Palestinian children and those from 57 other countries by operating on their diseased hearts. The doctors…

Read more »

Amazon’s Attack on the Pharmacy Industry Has Begun

Online retail giant Amazon is entering the pharmacy business after months of speculation that the company could disrupt how prescription drugs are sold — the same way it upended bricks-and-mortar…

Read more »

Report: Israelis Wait Too Long for Specialists

A new Health Ministry study released last week shows that Israelis are required to wait excessive amounts of time in order to see a medical specialist. The report, published in…

Read more »

Trump Assails High Drug Prices, Avoids Direct Hit on Industry

President Donald Trump on Friday blasted drugmakers and healthcare “middlemen” for making prescription medicines unaffordable for Americans, but healthcare stocks rose as his administration avoided aggressive direct measures to cut…

Read more »

Valeant, a New Business Model and Now, a New Name

Valeant Pharmaceuticals, which fell under withering scrutiny after acquiring the rights to drugs and then drastically raising their prices, is changing its name. The Canadian company said Tuesday that it…

Read more »

Teva Buoyed by First Quarter Earnings

Israeli generic drug maker Teva Pharmaceutical Industries says earnings jumped sharply in the first quarter of 2018 as it pressed forward with an aggressive cost-cutting program. Teva said it posted…

Read more »